Chemoinformaics analysis of Bicyclo[2.2.1]heptan-1-ol
| Molecular Weight | 112.172 | nRot | 0 |
| Heavy Atom Molecular Weight | 100.076 | nRig | 32 |
| Exact Molecular Weight | 112.089 | nRing | 2 |
| Solubility: LogS | -4.085 | nHRing | 0 |
| Solubility: LogP | 1.889 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 20 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 8 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 20.4935 |
| nHD | 1 | BPOL | 12.0385 |
| QED | 0.474 |
| Synth | 6.042 |
| Natural Product Likeliness | 3.323 |
| NR-PPAR-gamma | 0.652 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.973 |
| Pgp-sub | 0.125 |
| HIA | 0.234 |
| CACO-2 | -5.353 |
| MDCK | 0.00004 |
| BBB | 0.976 |
| PPB | 0.685458 |
| VDSS | 0.614 |
| FU | 0.348399 |
| CYP1A2-inh | 0.003 |
| CYP1A2-sub | 0.18 |
| CYP2c19-inh | 0.015 |
| CYP2c19-sub | 0.623 |
| CYP2c9-inh | 0.022 |
| CYP2c9-sub | 0.037 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.101 |
| CYP3a4-inh | 0.254 |
| CYP3a4-sub | 0.399 |
| CL | 8.884 |
| T12 | 0.122 |
| hERG | 0.002 |
| Ames | 0.053 |
| ROA | 0.986 |
| SkinSen | 0.017 |
| Carcinogencity | 0.833 |
| EI | 0.458 |
| Respiratory | 0.975 |
| NR-Aromatase | 0.642 |
| Antiviral | No |
| Prediction | 0.954615 |